DURECT -Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates

Durect (DRRX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of$ 0.17. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 29.41%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.21 per share when it actually produced a loss of $0.25, delivering a surprise of -19.05%. Over the last four quarters, the c ...